Adalimumab ELISA (mAb-based)
Enzyme immunoassay for the specific and quantitative determination of free Adalimumab (Humira®) in serum and plasma.
The solid phase (MTP) is coated with a highly specific monoclonal antibody against Adalimumab.
Therefore any cross reactivity to the other therapeutical monoclonal antibodies is excluded.
Reference: IG-AB103
Barcode: 8682754930103
Legal Status: CE-Mark
Intended Use: This kit has been developed for the measurement of drug levels in research and diagnostic uses. It is suitable for Therapeutical Drug Monitoring (TDM) purposes.
Assay Design:
Related Documents
Instructions for Use IG-AB103 698.57 KB
Material Safety Data Sheet (MSDS) IG-AB103 268.20 KB
Humira® is a trademark of Abbott Laboratories.
The Kit at a glance:
| Required Volume (µL) | 10 |
| Incubation Time (min) | 105 |
| Sample | Serum or Plasma |
| Package Size | 96 Tests |
| Standard Range (ng/mL, 10x) | 0-1500 |
| Sensitivity (ng/mL) | 3 |
| Spike Recovery (%) | >95 |
| Shelf Life (years) | 2 |
Standard Curve:
